Sustainability
In 2021, BICO set the foundation for the Group’s sustainability agenda. It connects bio convergence with three different perspectives that define our operations with UN Sustainability Development Goals. As of December 2021, BICO are an official signatory of the UN Global Compact Sustainability Development Goals and the Ten Principles of the United Nations Global Compact.
Three Dimensions
of Sustainability
The sustainability platform is gathered in The BICO Way, explains how BICO views sustainability and focuses on how we, as a company, can make a difference. The three perspectives form the pillars of our platform.
UN Sustainable Development Goals



The UN Sustainable Development Goals (SDGs) aim to end poverty and inequality, protect the planet and ensure that all people enjoy health, justice and prosperity. For the sustainability development goals, BICO have focused on goal 3, 9 and 12 since these are the goals that BICO can influence the most and which in turn impact BICO the most.
Code of Conduct
We will treat concerns with the gravity they deserve. We are working together with Whistlelink, which is an external, safe, and secure whistleblowing system that allows you to report suspected wrongdoings, easily and anonymously. We guarantee full anonymity, sensitivity and confidentiality throughout the entire case process. The system is available on BICO’s website, which enables reporting from third parties.
As an employee or a third party, you are encouraged to speak up and raise any and all ethical or legal concerns through our Whistleblower function.
Customer Case
3d Bioprinted Human Skin

The Future of Cosmetic Testing
CTIBiotech, an innovative R&D firm based in Lyon, France, is using CELLINK’s BIO X 3D bioprinter to produce in vitro full skin models from human cells. These bioprinted human skin models, which include sebaceous glands, immune cells or melanocytes, are more physiologically relevant. This improved models enable researchers to investigate sebum production, acne, or atopic dermatitis.
The $40 billion cosmetic industry is increasingly innovating using in vitro technologies as alternatives to animal experimentation for efficacy and safety testing skin-care and beauty products. Thankfully, advances in tissue engineering, such as the ability to bioprint human tissue models in the lab, have unlocked promising long-term-solutions.